Point-of-care (POC) blood gas and lactate analysis is an alternative choice that can reduce turnaround time, provide test results faster, and minimize pre-analytical errors, which may interfere with the test. Currently, benchtop blood gas and lactate analyzers are generally available in hospital units, such as intensive care units (ICUs) and perinatology units, and are considered the gold standard for blood gas measurements. 2 However, benchtop analyzers are not as portable are thus impractical for transport to another unit.
Laboratory tests using handheld POC devices can be carried out near the patient in any location. Therefore, the availability of blood gas and lactate handheld POC devices should shorten examination time, so that the management of emergency and critical patients can proceed quickly. Nevertheless, it is crucial to compare handheld POC devices with benchtop analyzers to evaluate whether their respective measurements are indeed comparable.
The i-STAT ® (Abbott point-of-care, Texas, USA) analyzer is a handheld blood gas and lactate POC analyzer that can deliver results quickly and be carried easily into any patient location in the hospital. 3, 4 The aims of this study were to study the agreement of blood gas and lactate test results between an i-STAT ® handheld POC device and a benchtop blood gas and lactate analyzer typically used in the central laboratory, and to determine whether there were any statistically or clinically significant biases between them. In addition, inter-device variability of the i-STAT ® handheld POC analyzer was also evaluated to determine whether different i-STAT ® handheld devices would give significantly different test results.
| MATERIAL S AND ME THODS
This study was performed in the central laboratory of Ciptomangunkusumo National Referral Hospital (Jakarta, Indonesia) between April and May 2017. The agreement of blood gas and lactate test results between the i-STAT handheld device and the central laboratory benchtop blood gas analyzer (Nova pHOx plus L ® , Nova Biomedical, Massachusetts, USA) was studied using 100 arterial blood samples sent for blood gas and lactate measurement to the central laboratory. The Clinical Laboratory Standards Institute (CLSI) guidelines recommend a minimum of 40 observations in method comparison studies, as stated in the CLSI Guidelines for Method Comparison and Bias Estimation Using Patient Samples (NCCLS document EP9-A2). 5 Analytical performances of the i-STAT ® and Nova pHOx plus L ® were also evaluated for precision. Inter-device variability of the i-STAT ® analyzers was also assessed by measuring three levels of control solution on three different i-STAT ® devices.
Arterial blood samples were collected from patients in the inpatient wards and ICUs in 3 cc blood gas syringes and were analyzed first on the central laboratory blood gas analyzer, the Nova pHOx plus L ® , and immediately thereafter on the i-STAT ® analyzer.
Exclusion criteria included specimen volumes <500 µL. Blood gas and lactate measurements required 125 μL specimen for the Nova pHOx plus L ® and 95 μL for the i-STAT ® analyzer. 3, 4 Specimens were analyzed on the i-STAT ® analyzer using CG4+ disposable cartridges.
The analytes being studied for blood gas were pH, pCO 2 , and pO 2 because other blood gas parameters (eg, total CO 2 , HCO 3 , Base Excess, and sO 2 ) are calculated based on the three aforementioned parameters on the i-STAT ® analyzer. 3 
Within-run and between-day precision tests for i-STAT ® and
Nova pHOx plus L ® analyzers were measured using three levels of control solutions. Within-run tests were performed 10 times for each level of control solution, while between-day tests were performed for 10 consecutive days. The results were then compared with precision data stated by the manufacturer. The inter-device variability of the i-STAT ® was evaluated with ANOVA or Kruskal-Wallis tests.
The correlation between the results from the i-STAT ® POC device and the Nova pHOx plus L ® analyzer was determined using Pearson and Spearman correlation coefficients. In addition, Bland-Altman analysis was used to measure the level of agreement between the i-STAT ® and the Nova pHOx plus L ® based on the values of bias and limits of agreement. Bland-Altman plots were made by plotting the differences between analyzers against the calculated means. The
Passing-Bablok regression test was performed to obtain the pH, pCO 2 , pO 2 , and lactate prediction equations to see whether there were constant or proportional differences in pH, pCO 2 , pO 2 , and lactate test results between the handheld and benchtop analyzers. 6 To assess whether the analytical differences between the i-STAT ® and Nova pHOx plus L ® may lead to clinically significant discrepancies, the values of bias between the analyzers were compared to acceptable analytical performance based on the 1992 Clinical Laboratory Improvement Amendments (CLIA) proficiency testing criteria target value for pH ± 0.04 pH units, for pCO 2 ± 5 mm Hg, and for pO 2 ± 3 SD. 
| RE SULTS
Results of the within-run and between-day imprecision study of the i-STAT ® and Nova pHOx plus L ® analyzers are summarized in Table 1 .
The precision profile of each analyzer for pH, pCO 2 , pO 2 , and lactate derived from this study showed comparable results to the claims by each manufacturer. In general, the precision profile of the i-STAT ® and the Nova pHOx plus L ® was considered equivalent.
Inter-device variability tests demonstrated no significant variability between the three i-STAT ® analyzers used in this study. There was no P-value below 0.05 in the inter-device variability tests, meaning no significant differences between the test results of the three analyzers were detected. The P-value of the inter-device variability tests is shown in Table 2 .
Strong correlation coefficients (r) between the test results
of the i-STAT ® and the Nova pHOx plus L ® were observed in the comparison study-pH (r = 0.893), pCO 2 (r = 0.843), pO 2 (r = 0.983), and lactate (r = 0.986); P < 0.001. The results of the Passing-Bablok regression test performed between the i-STAT ® and the Nova pHOx plus L ® are shown in Table 3 . There was no constant nor proportional bias observed between the analyzers for pH, while there was a constant bias for pCO 2 , a proportional bias for lactate, and both for pO 2 .
Bland-Altman analysis of pH results displayed the average bias for the i-STAT ® analyzer of 0.049 pH units lower than the Nova pHOx plus L ® with the 95% limits of agreement ranging from −0.027 to 0.124. The average bias of pCO 2 for the i-STAT ® was 0.28 mm Hg lower than the Nova pHOx plus L ® with 95% limits of agreement ranging from −14.16 to 14.71. The average bias of pO 2 was 2.16 mm Hg higher on the i-STAT ® compared with the Nova pHOx plus L ® with 95% limits of agreement ranging from −17.69 to 13.36.
The average bias of lactate for the i-STAT ® was 0.55 mmol/L lower than the Nova pHOx plus L ® with 95% limits of agreement ranging from −0.79 to 1.89. Bland-Altman plots showed that 96% of the pH differences were within the limits of agreement, with 95% for both pCO 2 and pO 2 differences, but only 93% for lactate differences.
Seven out of eight lactate differences outside the limits of agreement were higher than 8 mmol/L. Bland-Altman plots obtained in this study are shown in Figures 1-4 .
The mean biases of pCO 2 , pO 2 , and lactate measurements between the i-STAT ® and the Nova pHOx plus L ® analyzers were not considered clinically important according to acceptable analytical performance based on the 1992 CLIA Proficiency Testing criteria and the 2014 RCPA Allowable Limits of Performance target value. 7, 8 The mean biases obtained in this study were 0.28 mm Hg for pCO 2 (target value ± 5 mm Hg), −2.16 mm Hg for pO 2 (target value ± 3 SD, SD:
7.76 mm Hg), and 0.55 mmol/L for lactate pO 2 (target value ± 3 SD), and 0.55 mmol/L (target value was ± 1.0 mmol/L). The bias of pH measurement was 0.049, which was slightly higher than the target value of 0.04. guideline is direct ion selective electrode (ISE). 9 Currently, most blood The within-run tests on the i-STAT ® analyzer demonstrated a coefficient of variation (CV) <5% for blood gas and lactate when control materials were run 10 times covering three level of concentrations. Between-day precision tests of the i-STAT ® analyzer in this study demonstrated similar results. The precision test CVs acquired in this study were higher than in the study by Leino et al (2011) ; the CV of which was <3% for blood gas and lactate. 11 Karon et al (2007) reported that the CV of lactate precision tests using the i-STAT ® analyzer was 3%. 12 However, the CV of the i-STAT ® analyzer obtained in this study was less than the manufacturer CV of blood gases and lactate, except for level 1 pO 2 between-day test. 3 Precision test CVs of the Nova pHOx plus L ® in this study displayed similar results, with CV < 5% for blood gases and lactate.
TA B L E 1 Imprecision study results
Inter-device variability test of the i-STAT ® analyzer displayed no significant variability between the three i-STAT ® devices used in the study. This result confirms that the usage of multiple i-STAT ® analyzers in the hospital would not give significantly different blood gas and lactate measurement results. To the best of our knowledge, there has been no previous study investigating the inter-device variability of i-STAT ® handheld analyzers.
Blood gas and lactate measurement results in this study displayed strong correlation between the i-STAT ® device and the Nova pHOx plus L ® benchtop analyzer. Correlation coefficients are the statistical comparison of the degree of linear relationship between two variables, in this case blood gas analysis and lactate results between the two analyzers. 13 Previous studies by Leino et al (2011) and Karon et al (2007) compared the i-STAT ® POC handheld device to central laboratory analyzers, which also displayed strong correlation between the analyzers. 11, 12 Passing-Bablok regression test revealed that there was neither proportional nor constant difference for pH results between the two analyzers since the value zero was included in the 95% CI for intercept and value one was included in the 95% CI for slope, while other parameters displayed variable results. 6 Partial O 2 pressure measurement results revealed that there were both proportional and constant differences between the analyzers, while partial CO 2 pressure and lactate measurement results displayed proportional and constant differences between the two analyzers, respectively. The equations derived from the Passing-Bablok regression test may be useful for predicting measurement differences between the i-STAT ® and Nova pHOx plus L ® , in view of the fact that blood gas and lactate values derived from the i-STAT ® handheld analyzer and benchtop laboratory analyzer are frequently used interchangeably by clinicians.
Bland-Altman plots showed that 95% of the differences were between the range of the limits of agreement for pH, pCO 2 , and pO 2 , while for lactate it was only 93% of the differences were between limits of agreement. Discrepancies between the i-STAT ® and the Nova pHOx plus L ® were more significant for lactate values of more than 8 mmol/L (Figure 4) . Lactate values measured on the i-STAT ® analyzer were lower than on the Nova pHOx plus L ® . Karon et al (2007) had previously compared lactate measurements between the i-STAT ® and core laboratory analyzer (Vitros 250 ® ). 12 In that study, discrepancies were more significant at values >6 mmol/L, with i-STAT ® results being lower than those of the Vitros 250 ® . 12 Leino et al (2011) reported that i-STAT ® analyzers gave lower lactate values compared with core laboratory plasma analyzers, especially with high lactate concentrations. 11 The same tendency was observed by Ismail et al (2015) in their study comparing the i-STAT ® , GEM Premier 4000 ® , and OMNI S ® analyzers. 14 Therefore, clinicians should be informed that caution must be used when comparing high lactate values between the i-STAT ® device and central laboratory analyzers.
Clinically significant bias was observed for pH values measured
with the i-STAT ® analyzer since they were slightly higher than the target value of acceptable analytical performance. In spite of this, the majority of the results were within acceptable limits. However, any pH value that was near the upper or lower reference limit should be interpreted with caution. 7 Information regarding patient clinical condition, medical history, and treatments should be determined whenever possible.
In conclusion, the differences in blood gas (pH, pCO 2 , pO 2 ) and lactate values among the i-STAT ® POC analyzer and benchtop blood gas laboratory analyzer are negligible. However, medical facilities that use both the i-STAT ® analyzer and central laboratory benchtop blood gas analyzers should inform clinicians that caution must be used when comparing high lactate values between point-of-care and benchtop blood gas laboratory measurement results. There was no inter-device variability observed between different i-STAT ® devices, thus measurement results from multiple i-STAT ® analyzers can be employed interchangeably in daily practice.
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